JP2025505578A5 - - Google Patents

Info

Publication number
JP2025505578A5
JP2025505578A5 JP2024545928A JP2024545928A JP2025505578A5 JP 2025505578 A5 JP2025505578 A5 JP 2025505578A5 JP 2024545928 A JP2024545928 A JP 2024545928A JP 2024545928 A JP2024545928 A JP 2024545928A JP 2025505578 A5 JP2025505578 A5 JP 2025505578A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
formula
compound
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024545928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505578A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/061973 external-priority patent/WO2023150703A2/en
Publication of JP2025505578A publication Critical patent/JP2025505578A/ja
Publication of JP2025505578A5 publication Critical patent/JP2025505578A5/ja
Pending legal-status Critical Current

Links

JP2024545928A 2022-02-03 2023-02-03 T型カルシウムチャネル調節因子を使用した治療方法 Pending JP2025505578A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263306340P 2022-02-03 2022-02-03
US63/306,340 2022-02-03
PCT/US2023/061973 WO2023150703A2 (en) 2022-02-03 2023-02-03 Methods of treatment using t-type calcium channel modulators

Publications (2)

Publication Number Publication Date
JP2025505578A JP2025505578A (ja) 2025-02-28
JP2025505578A5 true JP2025505578A5 (enExample) 2026-02-12

Family

ID=87552982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024545928A Pending JP2025505578A (ja) 2022-02-03 2023-02-03 T型カルシウムチャネル調節因子を使用した治療方法

Country Status (10)

Country Link
US (1) US20250170114A1 (enExample)
EP (1) EP4472633A4 (enExample)
JP (1) JP2025505578A (enExample)
KR (1) KR20240144291A (enExample)
CN (1) CN118785905A (enExample)
AU (1) AU2023216271A1 (enExample)
CA (1) CA3243616A1 (enExample)
IL (1) IL314576A (enExample)
MX (1) MX2024009559A (enExample)
WO (1) WO2023150703A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025188619A1 (en) * 2024-03-04 2025-09-12 Praxis Precision Medicines, Inc. Methods of treating parkinson's disease with t-type calcium channel modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101212974A (zh) * 2005-06-29 2008-07-02 默克公司 4-氟-哌啶t-型钙通道拮抗剂
JP6790094B2 (ja) * 2015-11-12 2020-11-25 エーエフエーエスシーアイ,インコーポレイテッド イオンチャネル阻害化合物、医薬製剤および使用
US11744825B2 (en) * 2018-08-28 2023-09-05 Afasci, Inc. Methods of treating hypersensitive cough or itching using ion channel inhibitory compounds
EP3996746A4 (en) * 2019-07-11 2023-08-23 Praxis Precision Medicines, Inc. T-TYPE CALCIUM CHANNEL MODULATOR FORMULATIONS AND METHODS OF USE THEREOF
EP4142764A4 (en) * 2020-04-29 2024-05-29 Praxis Precision Medicines, Inc. Methods of use of t-type calcium channel modulators
WO2022099207A1 (en) * 2020-11-09 2022-05-12 Praxis Precision Medicines, Inc. T-type calcium channel modulators and methods of use thereof
CN119584962A (zh) * 2022-05-09 2025-03-07 普拉西斯精密医药公司 T型钙通道调节剂的使用方法

Similar Documents

Publication Publication Date Title
JP2022502500A5 (enExample)
JP2021525729A5 (enExample)
JP2023515472A5 (enExample)
JP2024515829A5 (enExample)
JP2022536287A5 (enExample)
TW200838545A (en) Therapeutic agent for painful disease
JP2005525369A5 (enExample)
JP2022527398A5 (enExample)
JP2022519744A5 (enExample)
JP2023524039A5 (enExample)
JP2020534270A5 (enExample)
JP2001509173A (ja) 胃腸リパーゼ阻害剤の使用
JP2021152060A (ja) アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法
JP2025515671A5 (enExample)
JP2022550919A5 (enExample)
JP2022532356A5 (enExample)
JP2021522344A5 (enExample)
JP2022521233A5 (enExample)
JP2024069223A5 (enExample)
JP2022529182A5 (enExample)
JP2023553253A5 (enExample)
JP2023548429A5 (enExample)
JP2023549849A5 (enExample)
JP2023541007A5 (enExample)
JP2023528896A5 (enExample)